ABSTRACT
A pooled crude data analysis showed a significant increase in the incidence of sPTB < 37 weeks in singleton IVF/ICSI pregnancies compared with those conceived spontaneously ( 
INTRODUCTION
Preterm birth (PTB), defined by the World Health Organization as delivery before 37 completed weeks of gestation, is the leading cause of infant morbidity and mortality in wealthy countries 1 . Previous research has shown that singletons conceived by in-vitro fertilization (IVF) have an increased risk of PTB compared with those conceived spontaneously 2 . As the number of women achieving pregnancy through IVF or intracytoplasmic sperm injection (ICSI) is increasing worldwide 3 , it has become pertinent to investigate the causes of PTB in these patients. PTB has often been regarded as a single entity, for statistical and epidemiological purposes 4 ; however, the risk factors, management and prognosis between the spontaneous (sPTB) and iatrogenic (iPTB) subtypes of PTB differ markedly. Most studies examining obstetric and perinatal outcomes in IVF/ICSI pregnancies have assessed PTB as an entity with no etiological differentiation 3, [5] [6] [7] . Studies examining the association between IVF/ICSI and the different subtypes of PTB are few [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and, to date, a meta-analysis of this literature has not been carried out. The aim of this study was to evaluate the association between IVF/ICSI and sPTB in singleton pregnancy and to give a quantitative estimation of the risk of sPTB in these pregnancies as compared with the risk in naturally conceived singletons.
METHODS

Search strategy
Studies comparing the risk of sPTB in IVF/ICSI vs spontaneous singleton pregnancy were identified from PubMed/Medline, Scopus and Web of Science published from inception of each database until September 2017. The electronic search, study selection and data extraction were carried out independently by three reviewers (P.C., V.G., A.I). A two-stage search strategy was employed. First, an electronic search was conducted using the keywords 'preterm delivery', 'in vitro fertilization', 'IVF', 'intracytoplasmic sperm injection', 'ICSI', 'assisted reproductive technology', 'ART' and 'pregnancy outcome' alone and in different combinations. To obtain additional data sources, a second-stage search was carried out, which involved manually searching relevant references cited in the key articles that were retrieved through the databases. Articles that did not involve classification of PTB into spontaneous and indicated/iatrogenic were excluded. An extensive search of the gray literature was also performed. Only cohort studies in the English language were included; case reports, reviews, publications with incomplete data and studies conducted on the same registry with overlapping years were excluded. In the case of missing data or doubt concerning inclusion of a study in the meta-analysis, the relevant corresponding author was contacted via e-mail for clarification.
Eligibility criteria
Cohort studies comparing the incidence of sPTB in singleton pregnancies conceived by IVF/ICSI treatment vs spontaneous conception were selected. Pregnancies resulting from oocyte donation or methods of medically assisted reproduction other than IVF/ICSI were, in general, not considered in the analysis. Studies involving frozen embryo transfer (FET) were included in the pooled crude analysis but excluded in order to perform a subgroup analysis without FET. A spontaneous conception group was used as the reference or control group in all studies. The study groups consisted of patients who conceived singletons after IVF or ICSI treatment. Cases with induction of labor or indicated delivery were excluded.
The primary outcome was sPTB due to spontaneous preterm labor with intact membranes, or preterm prelabor rupture of membranes with subsequent spontaneous labor, with PTB defined as a delivery occurring before 37 completed weeks of gestation. Other secondary outcomes relevant to sPTB were included, in agreement with the requirements of the core outcomes in women's and newborn health (CROWN) initiative 23 . The core outcomes of interest related to the mother were maternal mortality, maternal infection/inflammation and preterm prelabor rupture of membranes, whereas those related to the offspring were sPTB < 34, < 32 or < 28 weeks, offspring mortality, birth weight, neurodevelopmental morbidity, gastrointestinal morbidity, infection and respiratory morbidity 23, 24 . A secondary outcome analysis was performed if data were reported in at least two studies.
Study selection and data collection
The literature was screened and the full-text articles were identified independently by three reviewers (P.C., V.G., A.I.) based on the titles and abstracts of all identified citations. The full-text articles were then carefully evaluated by each reviewer independently; inclusion into the meta-analysis was based on the eligibility criteria. The final set of articles was approved based on the main exclusion criterion, which was the lack of classification of PTB into spontaneous and indicated/iatrogenic.
Data were extracted manually from the full-text articles and analyzed independently by two reviewers (V.G., A.I.); consensus was reached by discussing the final results with the lead and senior authors (P.C., A.F.). The extracted data included information on the study design, study population and exposure, and outcome measures. Raw data of the study outcome (sPTB or 'disease' events) from the 'exposed' IVF group and the 'unexposed' spontaneous conception group were extracted from each article, and used to create 2 × 2 tables that measured crude and adjusted odds ratios (ORs) and corresponding 95% CIs. Methods, results and discussion were reported according to the PRISMA statement 25 .
Risk of heterogeneity or bias and study quality
The following potential sources of heterogeneity within and across the included studies were assessed: protocols of the assisted reproductive technology (ART) techniques used, characteristics and size of the population, ultrasound and laboratory methodologies, methodologies used for IVF/ICSI procedures (differences due to the long publication time interval among included studies, from 1992 to 2016), collection of data and clinical protocols used for pregnancy follow-up (e.g. progesterone treatment). Other sources of bias were assessed, such as publication bias, funding bias and multiple citation bias (different studies with overlapping databases). The Newcastle-Ottawa Scale (NOS) was used to assess the quality of included studies in order to improve the interpretation of meta-analytic results 26 . According to NOS, selection of the study population, comparability of the study groups and outcome ascertainment are evaluated for all selected cohort studies. Each of these domains is allocated a certain number of items that assess the quality of the study. Eight items are evaluated, providing a total score ranging from 0 to 9 for each study.
Once the study quality has been assessed, its influence on the effect estimates (summary OR) can be evaluated by a sensitivity analysis.
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) 27 approach was used to assess more deeply the study quality 28 . GRADE incorporates the aspects of study limitations, inconsistency of results, indirectness of the evidence, imprecision and reporting bias. The quality of evidence for each outcome across all the studies is rated according to the factors outlined in the GRADE approach, including additional factors that may lead to rating up or down the quality of evidence. This system gives an overall indication of the clinical utility of the evidence produced, based upon confidence in the estimate.
Statistical analysis
The incidence of sPTB in IVF/ICSI and spontaneous pregnancies was calculated by pooling events and cases of all cohort studies (incidence of sPTB = total number of sPTB/total number of individuals). The 2 × 2 tables, which included raw data on the dichotomous study outcomes from each of the primary studies, were used to calculate the overall combined OR with 95% CI in order to assess the strength of the relationship between IVF and sPTB and other secondary outcomes. A meta-analysis was performed using a random-effects model. The significance of the combined OR calculated using the Mantel-Haenszel statistical method was determined by the Z-test and the P-value. Between-study heterogeneity was assessed using the chi-square test (chi-square-based Q statistic test) and the I 2 statistic. The I 2 index expresses the percentage of the total variation across studies that are due to heterogeneity. I 2 values of 25, 50 and 75% correspond to low, moderate and high heterogeneity, respectively 29, 30 . Each of the primary studies took into account maternal age as a major confounding factor for sPTB. Studies controlling for both maternal age and parity through restriction or matching at the design stage were pooled together and termed 'pooled matched data'. Subanalyses of studies excluding FET cases and studies published recently (after 2011) were also carried out. The crude and matched data and other subgroup analyses were pooled separately in order to compare differences in the outcome depending on confounding factors. A sensitivity analysis to assess the outcome in the highest quality studies was performed by pooling together only the studies with a NOS score of 8 or 9. Risk of publication bias was assessed by the use of funnel plots (with 95% pseudo CI), when appropriate. Statistical analyses were performed using RevMan version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). A power analysis was performed using PASS software for pooled crude data results. At the given sample size, the relative power at a Type-I error rate of 5% was calculated.
RESULTS
Study selection and characteristics
The electronic search generated a total of 674 records. Two additional publications 18, 21 were identified by examining the references of key articles, resulting in a total of 676 records screened at the title and abstract level. Of these, 605 records failed to meet the study selection criteria. After careful full-text review of the remaining 71 articles, 15 studies [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] met all the inclusion criteria and were included in the meta-analysis ( Figure 1 ). Twelve Only first author of each study is given. %?, proportion not specified; BMI, body mass index; DES, diethylstilbestrol; FET, frozen embryo transfer; GIFT, gamete intrafallopian transfer; GIM, gastrointestinal morbidity; IUI, intrauterine insemination; NM, early neurodevelopmental morbidity; NOS, Newcastle-Ottawa Scale quality; Obs, obstetric; Pop, population; PPROM, preterm prelabor rupture of membranes; prosp, prospective; RDS, respiratory distress syndrome; ZIFT, zygote intrafallopian transfer.
of the 15 studies included in the meta-analysis were based in a clinical setting, whereas the remaining three studies 14, 15, 17 included participants from a population setting (data taken from more than one clinic through a national registry). Three studies 15, 18, 21 included patients who underwent gamete intrafallopian transfer in the study group, but these patients were an insignificant minority. One study 18 also included a small proportion of patients who underwent intrauterine insemination in the study group. FET was excluded with certainty in five studies; in six studies this was unclear, in three it was included with an unspecified proportion over the total IVF/ICSI cases and in one it was included with a specified proportion (14%) ( Table 1 ). There was doubt concerning inclusion in the meta-analysis of one study 16 in which cases were defined as 'preterm labor'; the corresponding author was contacted via e-mail and stated that all cases were actually confirmed sPTB. Corresponding authors of other included studies were also contacted; however, no additional data were available for secondary outcome analysis. Study characteristics are summarized in Table 1 .
Synthesis of results
The pooled analysis of the primary outcome generated a total sample size of 61 677 births, comprising 8044 cases in the exposed IVF/ICSI group and 53 633 in the unexposed/spontaneous conception group. sPTB occurred in 810 (10.1%) IVF/ICSI and 2932 (5.5%) spontaneously conceived pregnancies (Figure 2a) . The pooled crude data analysis of the 15 studies showed a significant increase in the incidence of sPTB < 37 weeks in singleton IVF/ICSI pregnancies compared with those conceived spontaneously (OR, 1.75; 95% CI, 1.50-2.03; I 2 = 39%; P = 0.06; Figure 2a) . A power analysis of pooled crude data yielded a result of 100% for the collected sample size. The significant increase in the incidence of sPTB < 37 weeks in IVF/ICSI vs spontaneously conceived pregnancies observed in the pooled crude analysis was confirmed by a subgroup analysis of studies matching for both maternal age and parity (OR, 1.63; 95% CI, 1.30-2.05; I 2 = 33%; P = 0.14), of studies excluding cases of FET (OR, 1.92; 95% CI, 1.67-2.21; I 2 = 0%; P = 0.99) and of more recent studies (in or after 2011) with modern protocols (OR, 1.52; 95% CI, 1.21-1.91; I 2 = 9%; P = 0.33 ( Figure 3) . A pooled crude analysis of secondary outcomes showed a significant increase in sPTB < 34 weeks in pregnancies conceived after IVF/ICSI compared with those conceived spontaneously (37/1012 (3.6%) vs 24/1107 (2.2%); OR, 1.78; 95% CI, 1.03-3.08; I 2 = 6%; P = 0.34; Figure 2b) . None of the other secondary outcome analyses presented statistically significant results ( Figures S1-S7 ).
Sensitivity analysis
The study quality was assessed using the NOS (Table S1 ). The studies that scored 8 or 9 (in total 10 9,12-16,18,19,21,22 of the 15 studies) were pooled together in a secondary sensitivity analysis, which confirmed the significance of the effect obtained in the pooled crude analysis (OR, 1.66; 95% CI, 1.37-1.99; I 2 = 27%; P = 0.20; Figure 4 ). Therefore, the study quality had no influence on the effect estimate.
Publication bias, heterogeneity and study quality
No concerns of publication bias were raised from the analysis of the funnel plot 30 ( Figure 5 ).
Statistical heterogeneity was found to be low in all pooled analyses, ranging from I 2 = 39% in the pooled crude data, to I 2 = 27% in the sensitivity analysis. The low heterogeneity suggests that there was little variability between the different studies.
The quality scores that were assigned to each primary study were based on a set of questions that control the validity of the study designs and the reliability of the data produced. The NOS quality scores were high among 10 of the 15 studies that scored either 8 or 9 and only one study had a score as low as 6 (Table S1 ). The mean overall score for all 15 studies was 7.5 (SD 1.5).
The quality of evidence, according to GRADE, was low for the primary outcome analysis (sPTB < 37 weeks) of the 15 studies and very low for the secondary outcome analysis of sPTB < 34 weeks involving three studies 12, 16, 19 . This is mainly because any study design other than randomized controlled trials carries a high risk Katalinic (2004) 8 9 Ochsenkühn (2003) 10 Olivennes (1993) 11 Perri (2001) 12 Reubinoff (1997) 13 Seggers (2016) 14 Shevell (2005) 15 Stojnic (2013) 16 Tan (1992) 17 Tanbo (1995) 18 Tomic (2011) 19 Verlaenen (1995) 20 Wang (2002) 21 Wennerholm (1997) 12 Stojnic (2013) 16 Tomic (2011) Heterogeneity: tau 2 = 0.02; chi 2 = 2.14, df = 2 (P = 0.34); I 2 = 6%
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Test for overall effect: Z = 2.08 (P = 0.04) Figure 2 Forest plot of odds ratio for incidence of spontaneous preterm birth at < 37 (a) and < 34 (b) weeks' gestation in singleton pregnancies conceived after in-vitro fertilization/intracytoplasmic sperm injection (IVF) vs those conceived spontaneously (SC). Only first author is given for each study. M-H, Mantel-Haenszel.
of bias. The difference in the quality of evidence was due to the impact of the 'imprecision' parameter, which was greater in the secondary outcome as compared with the primary outcome analysis of these carefully selected cohort studies (Table S2) .
DISCUSSION
Summary of evidence
This study showed an increased risk, of about 80%, of sPTB at both < 37 and < 34 weeks' gestation in pregnancies conceived by IVF/ICSI compared with those conceived spontaneously (GRADE of evidence: sPTB < 37 weeks: low; sPTB < 34 weeks: very low).
Interpretation
PTB is a complex syndrome with several obstetric precursors, including spontaneous preterm labor with intact membranes, preterm prelabor rupture of membranes with subsequent preterm labor and indicated or iatrogenic preterm delivery 31 . Previous literature suggested an increased risk of PTB among singleton IVF pregnancies when compared with spontaneously conceived controls 3, [5] [6] [7] . However, these studies did not investigate the two different causes of PTB, spontaneous and indicated, and therefore provided little understanding of etiology. sPTB, in particular, is associated with less favorable neonatal outcomes in IVF compared with naturally conceived pregnancies 19 .
IVF Events Total
Events Total
Weight (%)
Odds ratio M-H, Random, 95% CI Odds ratio M-H, Random, 95% CI Study (a) Spontaneous conception Koudstaal (2000) 9 Ochsenkühn (2003) 10 Perri (2001) 12 Reubinoff (1997) 13 Seggers (2016) 14 Stojnic (2013) 16 Tanbo (1995) 18 Wang (2002) 21 Wennerholm (1997) 22 18 160 9 160 2. 
Figure 3
Forest plots for subgroup analysis of incidence of spontaneous preterm birth at < 37 weeks' gestation in singleton pregnancies conceived after in-vitro fertilization/intracytoplasmic sperm injection (IVF) vs those conceived spontaneously (SC), including only studies matched for both maternal age and parity (a), excluding cases of frozen embryo transfer (b) and including only studies published recently (in or after 2011) (c). Only first author is given for each study. M-H, Mantel-Haenszel.
Overall PTB and sPTB patterns are different due to iPTB, which is particularly frequent in IVF/ICSI 3 . Common indications for iPTB in IVF/ICSI singleton pregnancies are obstetric complications for which the risk is increased, including hypertensive disorders, fetal growth restriction, antepartum hemorrhage, congenital anomalies or maternal request/anxiety 3 .
All studies included in the meta-analysis and a further study (excluded for insufficient data) showed a high frequency of sPTB in the IVF/ICSI group [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] 32 . The incidence of sPTB in the pooled control group was relatively low (5.5%; 2932/53 633), whereas that in the pooled IVF/ICSI group was considerably higher (10.1%; 810/8044). The preselection of a control group 12 Reubinoff (1997) 13 Seggers (2016) 14 Shevell (2005) 15 Stojnic (2013) 16 Tanbo (1995) 18 Tomic (2011) 19 Wang (2002) 21 Wennerholm (1997) Test for overall effect: Z = 5.30 (P < 0.00001) Figure 4 Sensitivity analysis of studies with Newcastle-Ottawa Scale quality score of 8 or 9 comparing incidence of spontaneous preterm birth at < 37 weeks' gestation in singleton pregnancies conceived after in-vitro fertilization/intracytoplasmic sperm injection (IVF) vs those conceived spontaneously (SC). Only first author is given for each study. M-H, Mantel-Haenszel. 
Figure 5
Funnel plot (with 95% pseudo CI) investigating publication bias in 15 studies included in systematic review and meta-analysis comparing incidence of spontaneous preterm birth at < 37 weeks' gestation in singleton pregnancies conceived after in-vitro fertilization/intracytoplasmic sperm injection vs those conceived spontaneously. OR, odds ratio; SE, standard error.
of such relatively low risk was due to: (a) matching of the IVF/ICSI and spontaneous conception cohorts for many confounding factors (sometimes relevant to PTB; Table 1 ) and (b) the geographical origin of the patients from areas considered at lower risk of prematurity (11/15 central/northern Europe, 2/15 Israel, 1/15 Ireland-USA and 1/15 Australia). In addition, patients undergoing IVF/ICSI frequently present with characteristics considered protective for PTB (higher economic/educational status, higher compliance, absence of maternal infection or disease), whereas higher maternal age is a risk factor for hypertensive disorders, potentially increasing the rate of iPTB in both groups.
The characteristics of the infertile population (infertility or, more likely, its causes) or the types of infertility treatment received could contribute to the increased risk of PTB 25 . The incidence of PTB in a cohort of singleton IVF pregnancies appeared to be identical to that of matched controls achieving pregnancy spontaneously whilst waiting for IVF treatment and higher than that in the general population 33 . This suggests that infertility itself is a risk factor for PTB. However, a recent study found that subfertile patients and non-IVF ART patients had a risk of PTB quite similar to that of fertile women, whereas the OR of PTB for IVF/ICSI pregnancies was 1.55, thus indicating that the risk of PTB in IVF/ICSI patients is due to the treatment itself 34 . First-trimester combined screening in IVF/ICSI pregnancies obtained after fresh embryo transfer shows increased concentrations of free β-human chorionic gonadotropin and a reduction in pregnancy-associated plasma protein-A 35 . These biomarkers indicate abnormal placentation and may be the biochemical precursors of anomalous outcomes described in IVF/ICSI pregnancies. Blastocyst transfer is also associated with increased nuchal translucency measurement, likely due to delays in embryogenesis or placentation 36 . Mild abnormalities of placental function leading to fetal hypoxemia or chronic placental inflammation may contribute to sPTB, particularly in the IVF/ICSI group, in which patients are at a higher risk of placental insufficiency 37, 38 . In fresh embryo cycles, the risk of placental dysfunction is higher and our results showed a consistently higher risk for sPTB in this subgroup (Figure 3b) . Therefore, we believe that placental development plays a key role in the pathogenesis of sPTB in IVF/ICSI pregnancies.
Strengths and limitations
The strengths of this study include: originality, as this is the first meta-analysis reporting outcomes of sPTB, excluding iPTB, in IVF/ICSI pregnancies; novelty, as a new risk factor for prematurity in IVF/ICSI pregnancies is described; high statistical power; adherence to the CROWN initiative 23, 24 ; and quality assessment performed according to the GRADE method 27, 28 . The limitations of this study include: (1) the long publication interval of the included studies (1992-2016), which could be associated with possible differences in ART protocols (with recent approaches being safer due to antagonist protocols) and methods of obstetric care used across the different studies; however, a subanalysis of recent literature (published in or after 2011) minimized this limitation ( Figure 3c) ; (2) the use of progesterone in the study group was unknown (higher use expected in ART pregnancies); (3) the inclusion of patients who underwent low-technology ART and were at lower risk of sPTB in the IVF/ICSI groups (Tanbo et al. 18 included 41/355 patients who underwent intrauterine insemination); (4) lack of stratification or matching for all confounding factors (previous sPTB, maternal characteristics, age, cervical causes of infertility) 39 , although all studies included in our meta-analysis matched cases and controls for the most important confounding factors; (5) adjustment of our analysis for confounding factors was not possible due to missing data; (6) the inclusion of FET cases was unclear in six studies and FET was included, with unspecified or specified proportion, in four studies (Table 1) ; the risk of PTB after FET is generally believed to be lower as compared with fresh cycles of IVF/ICSI 22, 40 , however, a subanalysis excluding FET cases minimized this limitation (Figure 3b ). In summary, the magnitude of the effect described in our study may be underestimated due to the inclusion of cases that underwent progesterone treatment, low-technology ART or FET.
Implications for clinical practice and future research
This meta-analysis shows that singleton pregnancies conceived after IVF/ICSI are at a higher risk of sPTB by about 80% as compared with spontaneous conception. Screening for sPTB in IVF/ICSI pregnancies is advisable in order to apply preventive strategies [41] [42] [43] [44] [45] . Transvaginal cervical length measurement has been used successfully in symptomatic or asymptomatic women to predict sPTB [45] [46] [47] . It is unlikely that transvaginal cervical length would perform differently in IVF/ICSI pregnancies as compared with spontaneously conceived ones. However, further research on different subgroups of ART pregnancy is required to investigate the etiology of sPTB (infertility, ART treatments, abnormal placental function). The paucity of available data on the etiological differentiation of PTB in IVF/ICSI is critical and should stimulate researchers to present these outcomes in the future. In particular, we recommend clear classification of core outcomes of PTB, primarily distinguishing between spontaneous and iatrogenic forms of PTB 23, 24 .
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Figure S1 Forest plot of odds ratio for incidence of spontaneous preterm birth at < 32 weeks' gestation in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Figure S2
Forest plot of odds ratio for incidence of preterm prelabor rupture of membranes in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Figure S3
Forest plot of odds ratio for incidence of stillbirth in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Figure S4
Forest plot of odds ratio for incidence of perinatal mortality in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Figure S5
Forest plot of odds ratio for incidence of neonatal sepsis in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Figure S6
Forest plot of odds ratio for incidence of respiratory distress syndrome in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Figure S7
Forest plot of odds ratio for incidence of gastrointestinal morbidity in singleton pregnancies conceived after IVF/ICSI vs those conceived spontaneously. Only first author is given for each study.
Table S1
Newcastle-Ottawa Scale quality assessment for the cohort studies included in the analysis Table S2 IVF compared with spontaneous conception in spontaneous preterm birth
